France Healthcare Contract Manufacturing Market Size & Outlook
The healthcare contract manufacturing market in France is expected to reach a projected revenue of US$ 19,715.9 million by 2033. A compound annual growth rate of 11.6% is expected of France healthcare contract manufacturing market from 2025 to 2033.
France healthcare contract manufacturing market highlights
The France healthcare contract manufacturing market generated a revenue of USD 7,477.0 million in 2024 and is expected to reach USD 19,715.9 million by 2033.
The France market is expected to grow at a CAGR of 11.6% from 2025 to 2033.
In terms of segment, pharmaceutical was the largest revenue generating type in 2024.
Medical Devices is the most lucrative type segment registering the fastest growth during the forecast period.
Healthcare contract manufacturing market data book summary
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany healthcare contract manufacturing market is projected to lead the regional market in terms of revenue in 2033.
Germany is the fastest growing regional market in Europe and is projected to reach USD 31,776.9 million by 2033.
Furthermore, supportive government initiatives such as Choose France event, which showcases the country’s economic appeal and encourages foreign investments in the country, are anticipated to further boost the market.
Furthermore, there are several specialized pharmaceutical and biotechnology CDMOs in France, such as Recipharm, Viant Medical, CELLforCURE, Minakem, Siegfried, Aenova, Eurofins CDMO, and PX' Therapeutics, which is contributing to the market growth.
France Healthcare Contract Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Healthcare Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Pharmaceutical was the largest segment with a revenue share of 85.96% in 2024.
Horizon Databook has segmented the France healthcare contract manufacturing market based on pharmaceutical, medical devices covering the revenue growth of each sub-segment from 2021 to 2033.
Furthermore, supportive government initiatives such as Choose France event, which showcases the country’s economic appeal and encourages foreign investments in the country, are anticipated to further boost the market.
Furthermore, there are several specialized pharmaceutical and biotechnology CDMOs in France, such as Recipharm, Viant Medical, CELLforCURE, Minakem, Siegfried, Aenova, Eurofins CDMO, and PX' Therapeutics, which is contributing to the market growth.
France Healthcare Contract Manufacturing Market Type Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical
Medical Devices
France Healthcare Contract Manufacturing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Medical Device Companies
Pharmaceutical & Biopharmaceutical Companies
Others
Reasons to subscribe to Healthcare Contract Manufacturing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Healthcare Contract Manufacturing Market Outlook databook
Our clientele includes a mix of Healthcare Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Healthcare Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Healthcare Contract Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
France Healthcare Contract Manufacturing Market, 2021-2033 (US$M)